US · artificial intelligence · biotechnology · cancer diagnostics
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series D · May 2026 · $52M
Mattias Westman lead, Dr Stephen Quake, Sandy Weill, Seattle based family office
Reported by Ventureburn
Missing a round, or an investor who was in one? Tell us.